These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8974456)

  • 21. Native chemical ligation in the synthesis of internally modified oligonucleotide-peptide conjugates.
    Diezmann F; Eberhard H; Seitz O
    Biopolymers; 2010; 94(4):397-404. PubMed ID: 20593471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligonucleotide-peptide conjugates as potential antisense agents.
    Zubin EM; Romanova EA; Volkov EM; Tashlitsky VN; Korshunova GA; Shabarova ZA; Oretskaya TS
    FEBS Lett; 1999 Jul; 456(1):59-62. PubMed ID: 10452530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of oligoarginine-oligonucleotide conjugates and oligoarginine-bridged oligonucleotide pairs.
    Wei Z; Tung CH; Zhu T; Stein S
    Bioconjug Chem; 1994; 5(5):468-74. PubMed ID: 7849079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates.
    Mier W; Eritja R; Mohammed A; Haberkorn U; Eisenhut M
    Bioconjug Chem; 2000; 11(6):855-60. PubMed ID: 11087334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3'-methylphosphonate-modified oligo-2'-O-methylribonucleotides and their Tat peptide conjugates: uptake and stability in mouse fibroblasts in culture.
    Prater CE; Miller PS
    Bioconjug Chem; 2004; 15(3):498-507. PubMed ID: 15149177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Peptide-oligonucleotide conjugates as a new generation of antisense elements].
    Stetsenko DA; Arzumanov AA; Korshun VA; Gait MJ
    Mol Biol (Mosk); 2000; 34(6):998-1006. PubMed ID: 11186016
    [No Abstract]   [Full Text] [Related]  

  • 27. Fragment-based solid-phase assembly of oligonucleotide conjugates with peptide and polyethylene glycol ligands.
    Dirin M; Urban E; Noe CR; Winkler J
    Eur J Med Chem; 2016 Oct; 121():132-142. PubMed ID: 27236069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
    Diala I; Murao S; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of antisense oligonucleotide-peptide conjugate targeting to GLUT-1 in HepG-2 and MCF-7 Cells.
    Chen CP; Li XX; Zhang LR; Min JM; Chan JY; Fung KP; Wang SQ; Zhang LH
    Bioconjug Chem; 2002; 13(3):525-9. PubMed ID: 12009942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A concise method for the preparation of peptide and arginine-rich peptide-conjugated antisense oligonucleotide.
    Chen CP; Zhang LR; Peng YF; Wang XB; Wang SQ; Zhang LH
    Bioconjug Chem; 2003; 14(3):532-8. PubMed ID: 12757376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of oligonucleotide-peptide conjugates for biomedical and technological applications.
    Aviñó A; Grijalvo S; Pérez-Rentero S; Garibotti A; Terrazas M; Eritja R
    Methods Mol Biol; 2011; 751():223-38. PubMed ID: 21674334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death.
    Callebaut C; Jacotot E; Guichard G; Krust B; Rey-Cuille M; Cointe D; Benkirane N; Blanco J; Muller S; Briand J; Hovanessian AG
    Virology; 1996 Apr; 218(1):181-92. PubMed ID: 8615021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-(2-aminooxyethoxy)-2-(ethylureido)quinoline-oligonucleotide conjugates: synthesis, binding interactions, and derivatization with peptides.
    Hamma T; Miller PS
    Bioconjug Chem; 2003; 14(2):320-30. PubMed ID: 12643742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions.
    Astriab-Fisher A; Sergueev D; Fisher M; Shaw BR; Juliano RL
    Pharm Res; 2002 Jun; 19(6):744-54. PubMed ID: 12134943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups.
    Svinarchuk FP; Konevetz DA; Pliasunova OA; Pokrovsky AG; Vlassov VV
    Biochimie; 1993; 75(1-2):49-54. PubMed ID: 8504177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, biochemical, biophysical and biological properties of cooperative antisense oligonucleotides.
    Kandimalla ER; Manning A; Lathan C; Byrn RA; Agrawal S
    Nucleic Acids Res; 1995 Sep; 23(17):3578-84. PubMed ID: 7567472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and properties of modified oligonucleotides.
    Letsinger RL; Alul RA; Farooqui F; Gryaznov SM; Kinstler O
    Nucleic Acids Symp Ser; 1991; (24):75-8. PubMed ID: 1841386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vitro inhibition properties of oligonucleotide conjugates carrying amphipathic proline-rich peptide derivatives of the sweet arrow peptide (SAP).
    Grijalvo S; Eritja R
    Mol Divers; 2012 May; 16(2):307-17. PubMed ID: 22392648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol.
    Shoji Y; Ishige H; Tamura N; Iwatani W; Norimatsu M; Shimada J; Mizushima Y
    J Drug Target; 1998; 5(4):261-73. PubMed ID: 9713976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Covalent protein-oligonucleotide conjugates for efficient delivery of antisense molecules.
    Rajur SB; Roth CM; Morgan JR; Yarmush ML
    Bioconjug Chem; 1997; 8(6):935-40. PubMed ID: 9404669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.